Ionetix Corp / DE /

CIK 2108121fmd_035Y6473RMQ0Q1KMCC84V7N1PYManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.